within Pharmacolibrary.Drugs.J_AntiinfectivesForSystemicUse.J05A_DirectActingAntivirals.J05AP05_Simeprevir;

model Simeprevir
  extends Pharmacolibrary.Drugs.ATC.J.J05AP05;

  annotation (Documentation(
info       = "<html><body><table><tr><td>Drug:</td><td>J05AP05</td></tr><td>route:</td><td>oral</td></tr><tr><td>n-compartments</td><td>2</td></tr></table><p>Simeprevir is an oral hepatitis C virus (HCV) NS3/4A protease inhibitor that was used in combination with other antiviral agents for the treatment of chronic hepatitis C infection in adults. While it was approved by the FDA in 2013, its usage has largely been phased out in favor of newer direct-acting antivirals.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters were reported in healthy adult volunteers after oral administration.</p><h4>References</h4><ol><li><p>Ouwerkerk-Mahadevan, S, et al., &amp; Simion, A (2016). Drug-Drug Interactions with the NS3/4A Protease Inhibitor Simeprevir. <i>Clinical pharmacokinetics</i> 55(2) 197–208. DOI:<a href=&quot;https://doi.org/10.1007/s40262-015-0314-y&quot;>10.1007/s40262-015-0314-y</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/26353895/&quot;>https://pubmed.ncbi.nlm.nih.gov/26353895</a></p></li><li><p>Snoeys, J, et al., &amp; Ouwerkerk-Mahadevan, S (2017). Elucidating the Plasma and Liver Pharmacokinetics of Simeprevir in Special Populations Using Physiologically Based Pharmacokinetic Modelling. <i>Clinical pharmacokinetics</i> 56(7) 781–792. DOI:<a href=&quot;https://doi.org/10.1007/s40262-016-0476-2&quot;>10.1007/s40262-016-0476-2</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/27896690/&quot;>https://pubmed.ncbi.nlm.nih.gov/27896690</a></p></li><li><p>Soriano, V, et al., &amp; Peña, JM (2015). Drug interactions with new hepatitis C oral drugs. <i>Expert opinion on drug metabolism &amp; toxicology</i> 11(3) 333–341. DOI:<a href=&quot;https://doi.org/10.1517/17425255.2015.998997&quot;>10.1517/17425255.2015.998997</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/25553890/&quot;>https://pubmed.ncbi.nlm.nih.gov/25553890</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>",
    experiment (StartTime = 0, StopTime = 86400, Tolerance = 1e-9, Interval = 1)
  ));
end Simeprevir;
